Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q3 2014 · 10-Q
Revenue$126.38M$126.38M+7.2% vs Q3 2013 Net Income$6.40M$6.40M+33.6% vs Q3 2013 EPS Diluted$0.24$0.24+33.3% vs Q3 2013 Gross Profit$20,155,000+15.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Operating Cash Flowderived$9,541,000−14.0% Free Cash Flowderived$7,030,000−28.5% Margins · derivedGross margin15.9%+1.1 pt vs Q3 2013
Operating margin7.7%+2.1 pt vs Q3 2013
Net margin5.1%+1.0 pt vs Q3 2013
ended Feb 23, 2014 · filed Mar 28, 2014 · 33 d after period end